Christophe Blockeel

Christophe Blockeel is a Physician Scientist at Vrije Universiteit Brussel, specializing in Genetics Reproduction and Development Observational Clinical Sciences. He maintains active clinical and research positions at UZ Brussel, where he contributes significantly to reproductive medicine and assisted reproductive technologies.

His primary research interests focus on Reproductive Medicine, Assisted Reproductive Technology, Embryo Transfer, Oocyte Donation, and Infertility Treatment. His work addresses critical challenges in reproductive health, including optimizing IVF protocols, understanding genetic factors in fertility, and improving outcomes for diverse patient populations. His research fingerprint reveals substantial contributions to Ovulation Induction (100%), Embryo Transfer (87%), Gonadotropin Releasing Hormone (83%), Birth Rate (79%), Live Birth (76%), Oocytes (64%), Progesterone (52%), and Pregnancy Rate (49%).

Analysis of his recent publications shows a strong focus on clinical applications of reproductive technologies, with increasing attention to ethical considerations, patient diversity, and personalized treatment approaches. His work spans clinical trials, observational studies, and technological evaluations in reproductive medicine.

• UZ Brussel Foundation - Flora project (75,000€) (2021)

Dr. Blockeel actively mentors graduate students, with multiple doctoral and master's theses completed under his supervision. His academic activities include numerous conference presentations, workshop leadership, and media engagement to promote public understanding of reproductive health issues. He participates in key professional organizations and contributes to clinical guidelines development through activities like LOK BIVF UZ Brussel.

His work extends to clinical practice innovation, particularly through the Brussels IVF program, where he contributes to developing and refining fertility treatment protocols. Dr. Blockeel maintains strong collaborations with researchers across Europe, particularly through ESHRE (European Society of Human Reproduction and Embryology), where he participates in annual meetings and case discussions.